NCT01000896View on ClinicalTrials.gov

Study to Assess Safety and Tolerability of AZD0530 in Combination With Carboplatin and Paclitaxel

PHASE1WithdrawnINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

September 30, 2010

Study Completion Date

March 31, 2011

Conditions
CancerNon Small Cell Lung CancerEpithelial Ovarian Cancer
Interventions
DRUG

AZD0530

film coated tablet, PO, daily

DRUG

Carboplatin

intravenous, 3 weeks

DRUG

paclitaxel

intravenous, 3 weeks

Trial Locations (2)

Unknown

Research Site, Matsuyama

Research Site, Fukuoka

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY